DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mycamine (Micafungin) - Graft Versus Host Disease - Suspected Cause - Side Effect Reports


Index of reports > Cases with Graft Versus Host Disease (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mycamine (Micafungin) where reactions include graft versus host disease. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mycamine side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-29

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Off Label Use, Graft Versus Host Disease, Device Related Infection, Infection

Drug(s) suspected as cause:
    Dosage: 13 mg, uid/qd
    Administration route: Oral
    Indication: Stem Cell Transplant
    Start date: 2009-06-09

    Dosage: unk
    Indication: Antifungal Prophylaxis
    Start date: 2009-08-01

Other drugs received by patient: Insulin; Antihypertensives; Actigall; Metrol; Vitamin D; Norvasc; Corticosteroids; Folic Acid

Possible Mycamine side effects in female

Reported by a physician from France on 2011-10-20

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Capillary Leak Syndrome, Bronchopulmonary Aspergillosis, Enterococcal Sepsis, Graft Versus Host Disease

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:

Other drugs received by patient: Mycophenolate Mofetil (Cellcept); Norepinephrine Bitartrate; Piperacillin and Tazobactam; Levofloxacin; Solu-Medrol; Solu-Medrol

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017